AstraZeneca’s potential exit raises alarm for UK markets
‘I definitely love America,’ says chief executive Pascal Soriot, among other gushing statements
AstraZeneca
Trump tariff letters unnerve investors with banks worst hit as markets drop
Pharma companies also volatile in wake of letters from US president to 17 of them demanding lower prices
Trump threat to fire Fed chair sends Wall Street lower
Global shares tumble as chip-makers struggle for direction
The silence of the CEOs in the face of Donald Trump’s tariff chaos
A lack of audible protest against Trump’s tariff chaos is one of the biggest failures of leadership in corporate history
Johnson & Johnson warns pharma tariffs could cause drug shortages
Top drugmaker sticks to forecasts as earnings beat expectations but pencils in $400m hit from tariff impact on medical device business
China woos CEOs of big global companies against backdrop of US tariffs
China Development Forum in Beijing hears that the country is willing to open its market further to foreign investment
In the Trump era, Europe should shift its gaze towards China – Joseph Stiglitz
Nobel prize-winning economist says defence spending move by EU is sound economic policy
Pharma firms ‘disappointed and concerned’ by lack of State support for campaign against EU reforms
New regulations of pharma sector could cost jobs in Ireland, industry warned Government
European shares edge up to record highs
Wall Street’s main indices slipped after hotter-than-expected inflation data
Five years after Covid, we scorn health workers, ignore vaccines and work in our offices
What happened to the need to end commuting and presenteeism? Or to our gratitude for healthcare workers or our resolution to change how we care for older people?
Markets nudge upwards ahead of Fed rate cut announcement
On Iseq Dalata shares rise as do those of housebuilder Glenveagh
AstraZeneca warns of shifting UK vaccine production to US
Deadlock with the new Labour government over plans to cut state aid, the Financial Times reported on Thursday
Ryanair dominates Irish market with share buyback announcement
European stocks were flat after latest US jobless claims data helped ease concerns of slowdown
Markets hit a wall amid fears of US economic slowdown
Financials and tech stocks worst hit as indices show a sea of red
AstraZeneca targets $80bn revenue by 2030
Anglo-Swedish drugmaker to launch 20 new medicines by end of decade
Big pay rise for Smith & Nephew chief shows US-style packages have arrived in Europe
Company says corporate talent is increasingly mobile in a globalised world and investors must pay up if they want to retain top executives
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
Continent’s drugmakers need to pay up to attract and retain talent, says Pascal Soriot
Europe’s magnificent 11 stocks – the Granolas
Continent’s top firms drove most of European equity gains last year
Ireland is one of slowest countries in Europe for medical reimbursment, it’s ‘a bit of a travesty for patients’
AstraZeneca’s Alex Wilkes warns Ireland needs to speed up access to medicines and expand the breadth of its pharma sector
Global stocks flat as investors await earnings from heavyweights
Holiday for US markets make for thin trading
European shares edge lower despite strong earnings from Unilever and Kering
Smurfit Kappa advances in Dublin, while Disney gains on Wall Street
AstraZeneca suffers low profit, driving down shares
Company entered obesity drug race last year but its experimental pill remains in early-stage tests
‘I work in a frustration factory’: how to make workplaces run better
Stanford professors Huggy Rao and Bob Sutton share tips to remove bad ‘friction’ in companies
AstraZeneca to buy cancer drug developer in China for up to $1.2bn
Astra will acquire Shanghai-based Gracell for $2 a share
‘An offhand comment’: Louise Richardson on the President’s broadside in the neutrality debate
The Waterford-born academic and foreign policy expert was a low-profile figure until she became the focus of sharp criticism for chairing the Government’s forum on security
Global markets subdued as investors await interest rate announcements
In Dublin, shares were down on the day, in line with European peers.
European shares cap strong weak with Friday rebound
Iseq index finished the session up 1%, driven by growing optimism about the path for interest rates
European markets edge lower after batch of downbeat company earnings
Investors keep eye on geopolitical tensions ahead of trip by US president Joe Biden to Israel
AstraZeneca to pay €375m to settle Nexium, Prilosec litigation in US
Claims were filed against the company for failing to warn patients about the risk of chronic kidney disease
US targets 10 drugs for pricing negotiations in crackdown on costs
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
European stock markets edge lower after mixed bag of company earnings
Aer Lingus owner IAG was the biggest gainer on the FTSE 100 index
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices